logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11919926 B1

PDFFull Text
Date of Patent:
Mar. 05, 2024

Filed:

Apr. 29, 2021

Method of treating hiv-1 infection utilizing a multiepitope t cell immunogen comprising gag, pol, vif, and nef epitopes

Applicants:

Esteve Pharmaceuticals, S.a., Barcelona, ES;

Fundacio Privada Institut DE Recerca DE LA Sida—caixa, Badalona, ES;

Inventors:

Christian Brander, Tiana, ES;

Beatriz Mothe Pujadas, Barcelona, ES;

Anuska Llano, Castellar del Valles, ES;

Assignees:

ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES;

FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA—CAIXA, Badalona, ES;

Attorney:

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Primary Examiner:

Jeffrey S Parkin

Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 39/12 (2006.01); A61K 39/21 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); C12N 7/00 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/53 (2013.01); A61K 2039/545 (2013.01); A61K 2039/57 (2013.01); A61K 2039/575 (2013.01); C07K 2319/00 (2013.01); C07K 2319/35 (2013.01); C12N 2740/16022 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16222 (2013.01); C12N 2740/16322 (2013.01);
Abstract

The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.

Find Patent Forward Citations

Brander, Christian. (2024). Method of treating hiv-1 infection utilizing a multiepitope t cell immunogen comprising gag, pol, vif, and nef epitopes (U.S. Patent No. 11919926). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11919926

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…